Camp4 Therapeutics Corp (CAMP) Institutional Ownership

Ownership Summary

Camp4 Therapeutics Corp (NASDAQ:CAMP) appears in 41 institutional 13F filings for the quarter ending December 2025.

• Their combined ownership stood at 140.2% of outstanding shares in December 2025, up from 103.4% in September 2025.
• Their total shares held in CAMP increased 38.79% quarter over quarter, and separately, investors owning Camp4 Therapeutics increased 7.89% from a year ago.
• Of these 41 holders, 24 added to their stakes in Camp4 Therapeutics, 10 trimmed positions, and 7 made no changes.
• In total, institutional investors held 38.25Mn shares in Camp4 Therapeutics as of December 2025, up by 10.69Mn shares quarter on quarter, and up 25.33Mn shares year over year.
• Janus Henderson Group Plc is the top holder of Camp4 Therapeutics as of December 31, 2025, with 12.62Mn shares representing 46.25% of outstanding stock.
• The largest buyers of Camp4 Therapeutics for the quarter ending December 2025 were Janus Henderson Group Plc (6.31Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.53Mn), Stonepine Capital Management, LLC (1.16Mn), SILVERARC CAPITAL MANAGEMENT, LLC (653.59K), SummitTX Capital, L.P. (339.52K).
• The largest sales of CAMP for the quarter ending December 2025 came from Enavate Sciences GP, LLC (844.9K), ADAGE CAPITAL PARTNERS GP, L.L.C. (220.9K), Trails Edge Capital Partners, LP (44.42K), Barclays Plc (38.91K), 683 Capital Management, LLC (18.36K).
• Per Business Quant data, the top 10 holders of Camp4 Therapeutics for the quarter ending December 2025 are Janus Henderson Group Plc (12.62Mn), 5AM Venture Management, LLC (5.87Mn), FMR LLC (4.93Mn), Vivo Capital, LLC (4.25Mn), BALYASNY ASSET MANAGEMENT L.P. (2.63Mn), Enavate Sciences GP, LLC (2.19Mn), a16z Capital Management, L.L.C. (2.13Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.96Mn), Trails Edge Capital Partners, LP (1.94Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.53Mn).